1. Home
  2. UNCY vs CLIR Comparison

UNCY vs CLIR Comparison

Compare UNCY & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$5.78

Market Cap

126.4M

Sector

Health Care

ML Signal

HOLD

Logo ClearSign Technologies Corporation (DE)

CLIR

ClearSign Technologies Corporation (DE)

HOLD

Current Price

$0.56

Market Cap

33.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNCY
CLIR
Founded
2016
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
126.4M
33.4M
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
UNCY
CLIR
Price
$5.78
$0.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$44.50
$2.00
AVG Volume (30 Days)
343.1K
122.8K
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,153,000.00
Revenue This Year
N/A
$13.13
Revenue Next Year
N/A
$143.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.71
$0.46
52 Week High
$11.00
$1.60

Technical Indicators

Market Signals
Indicator
UNCY
CLIR
Relative Strength Index (RSI) 50.39 39.13
Support Level $5.69 $0.55
Resistance Level $6.30 $0.65
Average True Range (ATR) 0.34 0.05
MACD -0.05 0.00
Stochastic Oscillator 37.70 11.09

Price Performance

Historical Comparison
UNCY
CLIR

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

About CLIR ClearSign Technologies Corporation (DE)

ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.

Share on Social Networks: